137 related articles for article (PubMed ID: 26776301)
1. Alcohol drinking as an unfavorable prognostic factor for male patients with nasopharyngeal carcinoma.
Chen YP; Zhao BC; Chen C; Lei XX; Shen LJ; Chen G; Yan F; Wang GN; Chen H; Jiang YQ; Xia YF
Sci Rep; 2016 Jan; 6():19290. PubMed ID: 26776301
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.
Liu X; Li X; Jiang N; Lei Y; Tang LL; Chen L; Zhou GQ; Sun Y; Yue D; Guo R; Mao YP; Li WF; Liu LZ; Tian L; Lin AH; Ma J
Cancer; 2014 Jan; 120(1):68-76. PubMed ID: 24114075
[TBL] [Abstract][Full Text] [Related]
3. Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors.
Vlantis AC; Chan HS; Tong MC; Yu BK; Kam MK; van Hasselt CA
Head Neck; 2011 Aug; 33(8):1126-31. PubMed ID: 21755557
[TBL] [Abstract][Full Text] [Related]
4. Critical weight loss predicts poor prognosis in nasopharyngeal carcinoma.
Zeng Q; Shen LJ; Guo X; Guo XM; Qian CN; Wu PH
BMC Cancer; 2016 Feb; 16():169. PubMed ID: 26926144
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
[TBL] [Abstract][Full Text] [Related]
6. The Tumour Response to Induction Chemotherapy has Prognostic Value for Long-Term Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
Peng H; Chen L; Zhang Y; Li WF; Mao YP; Liu X; Zhang F; Guo R; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
Sci Rep; 2016 Apr; 6():24835. PubMed ID: 27099096
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
8. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
Tu X; Ren J; Zhao Y
Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
[TBL] [Abstract][Full Text] [Related]
11. Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
Li PJ; Jin T; Luo DH; Shen T; Mai DM; Hu WH; Mo HY
PLoS One; 2015; 10(10):e0141332. PubMed ID: 26506559
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
14. Excessive vitamin B6 during treatment is related to poor prognosis of patients with nasopharyngeal carcinoma: A U-shaped distribution suggests low dose supplement.
Li H; Chen M; Liang S; Wei X; Wang R; Cui C; Ruan G; Ou Q; Liu L
Clin Nutr; 2021 Apr; 40(4):2293-2300. PubMed ID: 33873269
[TBL] [Abstract][Full Text] [Related]
15. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.
Han P; Lin ZR; Xu LH; Zhong Q; Zhu XF; Liang FY; Cai Q; Huang XM; Zeng MS
Mol Med Rep; 2015 Jul; 12(1):401-9. PubMed ID: 25695839
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
Li Y; Chen QY; Tang LQ; Liu LT; Guo SS; Guo L; Mo HY; Chen MY; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Shao JY; Sun Y; Tan J; Chen S; Ma J; Zhao C; Mai HQ
BMC Cancer; 2017 Aug; 17(1):567. PubMed ID: 28836950
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
Yao JJ; He XJ; Lawrence WR; Zhang WJ; Kou J; Zhang F; Zhou GQ; Wang SY; Sun Y
Cell Physiol Biochem; 2018; 48(1):285-292. PubMed ID: 30011397
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
Cao C; Luo J; Gao L; Yi J; Huang X; Li S; Xiao J; Zhang Z; Xu G
Cancer Res Treat; 2017 Apr; 49(2):518-525. PubMed ID: 27554478
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
[TBL] [Abstract][Full Text] [Related]
20. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.
Luo XL; Zhong GZ; Hu LY; Chen J; Liang Y; Chen QY; Liu Q; Rao HL; Chen KL; Cai QQ
Oncotarget; 2015 Dec; 6(41):44037-48. PubMed ID: 26503474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
